Abstract
The potential role of PET/CT with radiolabeled Choline in patients with treated prostate cancer, has not been established yet and no precise indications exist about the use of this emerging modality. According to the literature, the most useful application of Choline PET/CT is represented by the restaging of the disease in case of biochemical relapse for the detection of local and/or, lymph-nodal and/or distant recurrence. Aim of this brief review is to summarize the results of the most relevant published studies with particular interest to a better understanding of the relationship between PSA, PSA kinetics and Choline PET/CT sensitivity and the potential use of PSA kinetics for an optimal selection of the patient population who may benefit the most from this diagnostic procedure especially early after the biochemical recurrence.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
